View Older Stories View More Recent Stories

Aug 30, 2022 08:00AM Bioventus to Present at the Morgan Stanley Global Healthcare Conference
Aug 11, 2022 07:00AM Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
Aug 3, 2022 07:12AM Bioventus (BVS) Receives FDA 510(k) Clearance for SonaStar Elite
Aug 3, 2022 07:00AM Bioventus Receives FDA 510(k) Clearance for SonaStar Elite  
Jul 26, 2022 07:00AM Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
May 10, 2022 07:00AM Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance
May 2, 2022 07:00AM Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis
Apr 26, 2022 09:06AM Bioventus (BVS) Reports Prelim Q1 Sales of $116.5M-$118.5M, Adjusted EBITDA of ($19.4M)-($19M)
Apr 26, 2022 09:05AM Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA
Apr 25, 2022 07:00AM Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
Apr 8, 2022 09:25AM Bioventus (BVS) TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives
Apr 8, 2022 09:15AM Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives
Apr 5, 2022 07:00AM Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton
Apr 4, 2022 07:00AM Bioventus (BVS) Exercises Call Option to Acquire CartiHeal
Apr 4, 2022 07:00AM Bioventus Exercises Call Option to Acquire CartiHeal
Mar 16, 2022 07:00AM Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference
Mar 10, 2022 07:00AM Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance
Mar 1, 2022 07:00AM Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
Feb 28, 2022 07:02AM Bioventus (BVS) Appoints Mark Singleton as CFO
Feb 28, 2022 07:00AM Bioventus Appoints Mark Singleton as Chief Financial Officer
Feb 22, 2022 07:00AM Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022
Jan 11, 2022 07:09AM Bioventus (BVS) Prelim. Q4 Revenue Tops Consensus
Jan 11, 2022 07:00AM Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue
Dec 28, 2021 07:00AM Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
Dec 21, 2021 09:25AM Bioventus Appoints Michelle McMurry-Heath to Board of Directors
Dec 20, 2021 08:36AM Bioventus (BVS) Granted US FDA Clearance for BoneScalpel Access
Dec 20, 2021 08:30AM Bioventus Receives US FDA Clearance for BoneScalpel® Access™
Nov 18, 2021 08:45AM Bioventus to Expand Operations and Manufacturing in Memphis
Nov 15, 2021 07:31AM Bioventus (BVS) Announces CFO to Step Down
Nov 15, 2021 07:30AM Bioventus Announces Chief Financial Officer Transition Plan
Nov 9, 2021 07:00AM Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance
Nov 1, 2021 08:30AM Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs
Oct 29, 2021 08:25AM Bioventus Completes the Acquisition of Misonix
Oct 27, 2021 04:15PM Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021
Oct 26, 2021 04:15PM Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus
Oct 18, 2021 08:00AM BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration
Sep 20, 2021 08:30AM DUROLANE® Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons
Aug 30, 2021 07:31AM Bioventus (BVS) Proceeds with Option Agreement to Acquire CartiHeal
Aug 30, 2021 07:30AM Bioventus Proceeds with Option Structure Agreement with CartiHeal
Aug 25, 2021 04:05PM Bioventus Invests in Trice Medical Minimally Invasive Technologies
Aug 23, 2021 08:30AM Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer
Aug 10, 2021 04:05PM Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance
Jul 29, 2021 04:08PM Bioventus (BVS) Acquires Misonix (MSON) for $28/sh
Jul 29, 2021 04:05PM Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix
Jul 29, 2021 04:00PM Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance
Jul 27, 2021 04:15PM Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference
Jul 14, 2021 04:07PM Bioventus (BVS) Appoints Mary Kay Ladone to its Board
Jul 14, 2021 04:05PM Bioventus Appoints Mary Kay Ladone to Board of Directors
Jul 13, 2021 08:30AM Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide
Jun 24, 2021 04:39PM Bioventus (BVS) Announces Investment in Vaporox
View More Recent Stories View Older Stories